What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.

Lumakras (Sotorasib)

Sezzle
Brand

Lumakras (Sotorasib)

Prescription Required

Strength
Qty
120mg

You'll have option to make 4 interest-free payments by credit card once your order is confirmed using Sezzle

We don't have this generic product yet!

Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.

  • Product Details

    Description

    Lumakras is a prescription medication for treating advanced or metastatic non-small cell lung cancer (NSCLC) with a specific genetic mutation called KRAS G12C. This mutation is present in about 13% of NSCLC cases and has historically been difficult to target with traditional treatments.

    Lumakras works by inhibiting the activity of the mutated KRAS protein, which is a gene responsible for the uncontrolled growth and spread of cancer cells. Lumakras attaches to the protein made by this gene mutation, rendering the protein inactive, which inhibits cancerous cell growth.


    Fact Table

    Formula

    C30H30F2N6O3

    License

    US DailyMed

    Bioavailability

    -

    Legal status

    Rx-Only

    Chemical Name

    Sotorasib

    Elimination half-life

    5 hours

    Dosage (Strength)

    120mg

    Pregnancy

    Consult Doctor

    Brands

    Lumakras

    Protein binding

    -

    PubChem CID

    137278711

    MedlinePlus

    a621036

    ChEBI

    178199

    ATC code

    L01XX73

    DrugBank

    DB15569

    KEGG

    D12055

    Routes of administration

    By mouth

    Directions

    The usual dosage is 960 mg by mouth once daily. Lumakras should be taken with or without food.

    Ingredients

    The active ingredient is Sotorasib.

    Interactions

    Common drug-drug interactions include:

    • Abemaciclib
    • Antihepaciviral Combination Products
    • Asunaprevir
    • Avacopan
    • Avanafil
    • Avapritinib
    • Axitinib
    • Bedaquiline
    • Elacestrant
    • Elbasvir and Grazoprevir
    • Encorafenib
    • Entrectinib
    • Fedratinib
    • Fexinidazole
    • Finerenone
    • Flibanserin
    • Ganaxolone
    • Lumateperone
    • Lurbinectedin
    • Mavacamten
    • Mobocertinib
    • Neratinib
    • Nirmatrelvir and ritonavir
    • Lovastatin
    • Simeprevir
    • Sonidegib
    • Tazemetostat
    • Topotecan

    Cautions

    Do not use Lumakras if you do not have the KRAS G12C mutation. It is not effective in treating other types of lung cancer.

    Tell your healthcare provider if you have a history of lung or breathing problems before using Lumakras. The medication can cause lung inflammation, which can be serious or life-threatening.

    Your healthcare provider should administer a liver function test every three weeks for the first three months of treatment.

    Side Effects

    Common side effects may include:

    • Edema
    • Skin rash
    • Decreased serum albumin
    • Decreased serum calcium
    • Decreased serum sodium
    • Abdominal pain
    • Decreased appetite
    • Diarrhea
    • Nausea
    • Vomiting
    • Increase in urinary protein
    • Decreased hemoglobin
    • Lymphocytopenia
    • Prolonged partial thromboplastin time
    • Hepatotoxicity
    • Increased serum alanine aminotransferase
    • Increased serum alkaline phosphatase
    • Increased serum aspartate aminotransferase
    • Fatigue
    • Arthralgia
    • Musculoskeletal pain
    • Cough
    • Dyspnea
    • Pneumonia
    • Cardiac failure
    • Gastric ulcer
    • Interstitial pulmonary disease
    • Pneumonitis
    • Respiratory failure

    References

    1. Lumakras [package insert]. Thousand Oaks, CA: Amgen; 2021.


    IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

    Product Code : 13778

  • Product Reviews

Processing..

Please wait while the page is loading. Do not hit refresh or the browser back button to avoid any loss of information.

If you have any questions or concerns, please contact our Customer Service team via the chat option on our website or calling us toll free at: 1-800-891-0844